Clinical Trial Update: EXTEND EXpanding Treatment for Existing Neurological Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an extended treatment approach for existing neurological disease in sickle cell anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Anemia | Phase 2 | Status: COMPLETED